The AstraZeneca – Cambridge is looking for an interested candidate for the position of Bioanalytical Senior Scientist. The purpose of Innovative Medicines and Early Development (IMED) is to deliver candidate drugs into full clinical development. As part of Senior Scientist, the role of Drug Safety and Metabolism (DSM) is to characterize the non-clinical toxicology, off-target pharmacology, metabolism and pharmacokinetics of compounds. We also manage all non-clinical safety assessment as candidate drugs progress through late stage development, launch and life-cycle management.
- Undergraduate or Masters level qualification in a relevant field.
- Prior research experience in the pharmaceutical or biotech industry or academic research laboratory preferred.
- Quantitative Bioanalytical chemistry
- Biofluid and tissue sample analysis
- Analytical techniques e.g. LC-MS/MS, LC-UV, ligand binding
- Development, improvement and validation of Bioanalytical methods
- Has a good, practical, understanding of study design and PK/TK data analysis
- An understanding of automation, liquid handling, instrument validation and data handling
|Employer||AstraZeneca – Cambridge|
|Location||Cambridge (Babraham), UK|
- To develop methods, design, perform, identify and solve problems and summarize data from bioanalytical and toxicology studies to achieve Project Team objectives
- To ensure all work meets GLP or appropriate standards for investigational toxicology support
- Work collaboratively with external partners (CRO) where appropriate
- Act as Principal Investigator in Bioanalytical and Toxicokinetic evaluations to Safety studies
- Responsible for and ensure that the results of own experiments are recorded accurately and reported to a high standard in accordance with external and internal regulations
- To build an awareness of current scientific development relevant to a particular area of bioanalytical science or pharmacokinetics
Closing Date: 9th February 2016
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.